Common Shares Outstanding: The number of class A shares currently held by investors.
Madrigal Pharmaceuticals, Inc. (MDGL) had Common Shares Outstanding of 23.09M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$364.25M |
|
$-57.94M |
|
$40.01M |
|
$324.25M |
|
$420.56M |
|
$-56.31M |
|
$-1.63M |
|
$-57.94M |
|
$-57.94M |
|
$-57.94M |
|
$-57.94M |
|
$-57.94M |
|
$-57.94M |
|
$-56.31M |
|
$-54.82M |
|
29.14M |
|
29.14M |
|
$-1.99 |
|
$-1.99 |
|
| Balance Sheet Financials | |
$1.20B |
|
$11.59M |
|
$45.47M |
|
$1.24B |
|
$374.20M |
|
$340.79M |
|
$346.72M |
|
$720.92M |
|
$523.72M |
|
$516.54M |
|
$523.72M |
|
|
Common Shares Outstanding |
23.09M |
| Cash Flow Statement Financials | |
$-144.11M |
|
$226.39M |
|
$5.44M |
|
$203.78M |
|
$292.88M |
|
$89.10M |
|
$69.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.20 |
|
-- |
|
-- |
|
0.39 |
|
0.65 |
|
89.02% |
|
-15.46% |
|
-15.46% |
|
-- |
|
-15.91% |
|
-15.91% |
|
$-152.21M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.40 |
|
1.89 |
|
47.52 |
|
-11.06% |
|
-11.22% |
|
-4.66% |
|
-6.70% |
|
$22.68 |
|
$-5.22 |
|
$-4.94 |
|